Joshua Schiffman, MD-title-h1

Investigator Spotlight: Joshua Schiffman, MD

In the Spotlight
December 20, 2018

“ Kids First is a valuable program because it allows us to understand the genetic risks for cancer in children, and most importantly, begin to think about ways to translate these findings into cancer prevention and new treatments for children with cancer. ” - Dr. Joshua Schiffman

Dr. Joshua Schiffman is a pediatric oncologist at the University of Utah, where he is a Professor of Pediatrics and an Adjunct Professor of Oncological Sciences. Dr. Schiffman works as an Investigator at Huntsman Cancer Institute (HCI) and his laboratory explores the translation of cancer genomics and evolutionary medicine into patient care. Dr. Schiffman also serves as the Medical Director for the Family Cancer Assessment Clinic at HCI where he oversees the care of children and families with high genetic risk for cancer. Dr. Schiffman graduated from Brown University School of Medicine, followed by clinical training in Pediatrics and Pediatric Hematology-Oncology at Stanford University. Dr. Schiffman’s clinical expertise includes hereditary cancer predisposition, cancer risk assessment, and cancer genomics. He is the Principal Investigator (PI) on Project GENESIS (Genetics of Ewing Sarcoma International Study) one of the largest genetic epidemiology studies to explore the genetic risk of developing Ewing sarcoma, a rare but aggressive childhood bone tumor.

Icon Media Inquiries

Get Regular Updates


Stay in the loop with data sharing and Kids First DRC news.

Sign up for updates

For Media Inquiries


Please contact Bobby Moulder, Children’s Hospital of Philadelphia.

Contact Us